Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.52 USD | +6.67% | +11.27% | -51.99% |
Business Summary
Number of employees: 179
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Precision Oncology Drugs
100.0
%
| 132 | 100.0 % | 51 | 100.0 % | -61.21% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
51.1
%
| 15 | 11.5 % | 26 | 51.1 % | +71.71% |
Switzerland
28.4
%
| 117 | 88.5 % | 15 | 28.4 % | -87.56% |
Japan
20.5
%
| - | - | 11 | 20.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lloyd Segal
CEO | Chief Executive Officer | 60 | 31/05/16 |
Steve Forte
DFI | Director of Finance/CFO | 45 | 30/09/19 |
Michael Zinda
CTO | Chief Tech/Sci/R&D Officer | 53 | 30/04/19 |
Maria Koehler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/04/19 |
Robin T. Garner
IRC | Investor Relations Contact | - | - |
Daniel Bélanger
HRO | Human Resources Officer | - | 08/05/23 |
Philip Herman
PRN | Corporate Officer/Principal | - | 04/01/22 |
Kim Seth
PRN | Corporate Officer/Principal | - | 31/05/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 28/02/19 |
Lloyd Segal
CEO | Chief Executive Officer | 60 | 31/05/16 |
Ann Rhoads
BRD | Director/Board Member | 58 | 09/06/20 |
Todd Foley
BRD | Director/Board Member | 52 | 31/05/17 |
David Bonita
BRD | Director/Board Member | 48 | 31/08/19 |
Susan Molineaux
BRD | Director/Board Member | 70 | 07/06/23 |
Briggs Morrison
BRD | Director/Board Member | 65 | 31/05/17 |
Thomas Civik
CHM | Chairman | 55 | 06/09/21 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 31/10/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 42,445,406 | 42,001,104 ( 98.95 %) | 0 | 98.95 % |
Company contact information
Repare Therapeutics, Inc.
7171 Frederick-Banting Suite 270
H4S 1Z9, Saint-Laurent
+
http://www.reparerx.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.99% | 140M | |
+20.35% | 42.68B | |
-2.73% | 42.4B | |
+45.09% | 40.04B | |
-6.20% | 28.31B | |
+6.10% | 24.94B | |
-21.55% | 18.96B | |
+30.47% | 12.3B | |
-3.00% | 11.95B | |
-3.62% | 11.55B |
- Stock Market
- Equities
- RPTX Stock
- Company Repare Therapeutics Inc.